JP2013542955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542955A5 JP2013542955A5 JP2013537733A JP2013537733A JP2013542955A5 JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5 JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- compound
- hcv
- compound according
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40898910P | 2010-11-01 | 2010-11-01 | |
| US61/408,989 | 2010-11-01 | ||
| PCT/US2011/058404 WO2012061248A2 (en) | 2010-11-01 | 2011-10-28 | Novel specific hcv ns3 protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542955A JP2013542955A (ja) | 2013-11-28 |
| JP2013542955A5 true JP2013542955A5 (enExample) | 2015-02-12 |
| JP5828903B2 JP5828903B2 (ja) | 2015-12-09 |
Family
ID=46025037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537733A Expired - Fee Related JP5828903B2 (ja) | 2010-11-01 | 2011-10-28 | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8729014B2 (enExample) |
| EP (1) | EP2635570B1 (enExample) |
| JP (1) | JP5828903B2 (enExample) |
| CN (1) | CN103328466B (enExample) |
| AU (1) | AU2011323658A1 (enExample) |
| BR (1) | BR112013010836A2 (enExample) |
| CA (1) | CA2815855C (enExample) |
| IL (1) | IL225908A0 (enExample) |
| MX (1) | MX2013004906A (enExample) |
| WO (1) | WO2012061248A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103096891A (zh) | 2010-06-24 | 2013-05-08 | 判米德有限公司 | 利用羟氯喹或羟氯喹和抗病毒剂的组合治疗丙型肝炎病毒相关疾病 |
| JP5828903B2 (ja) | 2010-11-01 | 2015-12-09 | アールエフエス ファーマ，エルエルシー | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
| EP2723337A1 (en) | 2011-06-23 | 2014-04-30 | Panmed Ltd. | Treatment of hepatitis c virus |
| EP2802574A4 (en) | 2012-01-12 | 2015-06-24 | Rfs Pharma Llc | INHIBITORS OF HCV NS3 PROTEASE |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| ES2735355T3 (es) | 2013-03-15 | 2019-12-18 | Gilead Sciences Inc | Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C |
| JP2017513852A (ja) * | 2014-04-15 | 2017-06-01 | コクリスタル ファーマ，インコーポレイテッド | Ｃ型肝炎ウイルスの強力及び選択的な阻害剤 |
| CN105315261A (zh) * | 2014-08-04 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Hcv ns3蛋白酶抑制剂的钠盐 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000536A1 (en) | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| UA79749C2 (en) | 1996-10-18 | 2007-07-25 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| ATE297946T1 (de) | 2000-04-03 | 2005-07-15 | Vertex Pharma | Inhibitoren von serin proteasen, speziell der hepatitis-c-virus ns3-protease |
| EP1425029A4 (en) | 2001-08-10 | 2006-06-07 | Palatin Technologies Inc | PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| US7041698B2 (en) | 2002-05-20 | 2006-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EA010017B1 (ru) | 2003-07-10 | 2008-06-30 | Ачиллион Фармасьютикалз, Инк. | Замещённые арилтиомочевины, применимые в качестве ингибиторов репликации вирусов |
| SI1713823T1 (sl) | 2004-01-30 | 2010-04-30 | Medivir Ab | Inhibitorji HCV NS-3 serin proteaze |
| MXPA06013404A (es) | 2004-05-20 | 2007-01-23 | Schering Corp | Prolinas sustituidas como inhibidores de serina proteasa ns3 de virus de hepatitis c. |
| US7323447B2 (en) * | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN100486397C (zh) | 2005-04-19 | 2009-05-06 | 皇家飞利浦电子股份有限公司 | 包括红色发射陶瓷发光转换器的照明系统 |
| US7470664B2 (en) | 2005-07-20 | 2008-12-30 | Merck & Co., Inc. | HCV NS3 protease inhibitors |
| JP4705984B2 (ja) | 2005-08-01 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｃｖｎｓ３プロテアーゼ阻害剤としての大環状ペプチド |
| JP2009524681A (ja) | 2006-01-27 | 2009-07-02 | フェノミックス コーポレーション | Ｃ型肝炎ウイルスセリンプロテアーゼインヒビターおよびそのための使用 |
| CN101495457A (zh) * | 2006-07-05 | 2009-07-29 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| JP5035251B2 (ja) | 2006-11-24 | 2012-09-26 | 株式会社島津製作所 | Ｘ線透視撮影装置 |
| US20080287449A1 (en) | 2007-04-26 | 2008-11-20 | Deqiang Niu | Aza-tripeptide hepatitis c serine protease inhibitors |
| CN101977621A (zh) | 2007-12-05 | 2011-02-16 | 益安药业 | 氟化三肽hcv丝氨酸蛋白酶抑制剂 |
| TWI487522B (zh) | 2007-12-21 | 2015-06-11 | 賽基艾維洛米斯研究股份有限公司 | Ｈｃｖ蛋白酶抑制劑及其用途（一） |
| US8293705B2 (en) | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| KR20110005869A (ko) | 2008-04-15 | 2011-01-19 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제 |
| KR101781789B1 (ko) * | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물 |
| JP5828903B2 (ja) | 2010-11-01 | 2015-12-09 | アールエフエス ファーマ，エルエルシー | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
-
2011
- 2011-10-28 JP JP2013537733A patent/JP5828903B2/ja not_active Expired - Fee Related
- 2011-10-28 CN CN201180063866.1A patent/CN103328466B/zh not_active Expired - Fee Related
- 2011-10-28 WO PCT/US2011/058404 patent/WO2012061248A2/en not_active Ceased
- 2011-10-28 BR BR112013010836A patent/BR112013010836A2/pt not_active IP Right Cessation
- 2011-10-28 MX MX2013004906A patent/MX2013004906A/es active IP Right Grant
- 2011-10-28 US US13/284,641 patent/US8729014B2/en not_active Expired - Fee Related
- 2011-10-28 AU AU2011323658A patent/AU2011323658A1/en not_active Abandoned
- 2011-10-28 CA CA2815855A patent/CA2815855C/en not_active Expired - Fee Related
- 2011-10-28 EP EP11838590.5A patent/EP2635570B1/en not_active Not-in-force
-
2013
- 2013-04-23 IL IL225908A patent/IL225908A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542955A5 (enExample) | ||
| JP2012528161A5 (enExample) | ||
| JP2011528713A5 (enExample) | ||
| JP2013510120A5 (enExample) | ||
| JP2009504763A5 (enExample) | ||
| JP2011079828A5 (enExample) | ||
| JP2012504126A5 (enExample) | ||
| JP2019526596A5 (enExample) | ||
| JP2014504643A5 (enExample) | ||
| JP2008530096A5 (enExample) | ||
| EP2368900A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2012513479A5 (enExample) | ||
| RU2015114543A (ru) | Способы лечения гепатита с | |
| JP2015024998A5 (enExample) | ||
| JP2011520906A5 (enExample) | ||
| JP2011515398A5 (enExample) | ||
| JP2010509359A5 (enExample) | ||
| JP2012504132A5 (enExample) | ||
| JP2010510233A5 (enExample) | ||
| JP2012516871A5 (enExample) | ||
| JP2012512169A5 (enExample) | ||
| TN2012000009A1 (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| JP2010510967A5 (enExample) | ||
| JP2014508804A5 (enExample) | ||
| JP2013541514A5 (enExample) |